LABS.JK PT UBC Medical Indonesia Tbk

Healthcare Medical Devices Jakarta Exchange
125.00 IDR
Close of Oct 29, 2026
125.00 216.00
Market cap
IDR 498B
P/E
-
P/B
-
ROE
5.4%
Dividend yield
-
Fundamental score
2.0/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is LABS.JK undervalued?

Graham number

The Graham number of PT UBC Medical Indonesia Tbk cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

PT UBC Medical Indonesia Tbk fundamental analysis

8 of 22 checks passed

ROE 0/2

Low return on equity (5.4%), below 10%.

ROA 1/1

Return on assets (3.8%) is above the industry median (-7.4%).

Profit Consistency 2/2

Profitable for 5 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share history is shorter than 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 1/1

Last year's EPS growth (206.0%) is above the industry median (5.2%).

Revenue Growth 2/2

Revenue grew 28.8% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (15.2%), 40% or less.

Debt Trend 0/1

Debt to equity history is shorter than 5 years.

Debt Coverage 0/1

Operating cash flow does not cover 20% of total debt.

Interest Coverage 1/1

EBIT is 11.4x against interest expense, well covered.

PE vs Market 0/1

PE is negative or not available.

PE vs Industry 0/1

PE is negative or not available.

PBV 0/1

Price to book is negative or not available.

Graham Number 0/1

Graham number needs positive earnings and book value.

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

PT UBC Medical Indonesia Tbk stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About PT UBC Medical Indonesia Tbk

PT UBC Medical Indonesia Tbk distributes medical devices in Indonesia. It operates in two segments, Medical Disposables and Consumables; and Diagnostics and Equipment. The company offers NeoMoDX molecular system; Revvity SARS-COV-2 RT PCR and Geneproof SARS-COV-2 PCR KIT; Airdoc Retina AI, a screening technology that uses Artificial Intelligence (AI) to detect chronic diseases such as diabetic retinopathy and hypertension; Hisky; and All-in-one GP workstation. It also provid…

Full company profile